LUCENTIS *
- Ranibizunab -@- Ophthalmic agents - Selective Vascular Endothelial Growth Factor Antagonist
Compositions:
Ranibizumab 10mg/ml ophthalmic injection in 2ml single use vial ,
List of Related Indications:
Ranibizumab 10mg/ml ophthalmic injection in 2ml single use vial ,
- Macular degeneration
Strength | Rate | Packing Style |
---|---|---|
10mg/ml opth. inj. | 0.00 | 2ml in single use vial |